Tris Pharma has set its sights on an FDA filing for pipeline drug cebranopadol before the end of this year after the drug achieved significant pain relief in abdominoplasty patients in a late-stage ...
Good, N. E., Winger, G. D., Winter, W., Connolly, T. N., Izawa, S., and Singh, R. M. M., Biochemistry, 5, 467 (1967).
We investigated the association between exposure to 29 organophosphate esters (OPEs) and the onset of childhood asthma and recurrent wheeze. Using a case-cohort design nested in the Canadian CHILD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results